• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童伴 - 相关过度生长谱的乳腺内淋巴管内血管内皮瘤:PI3K 通路在血管肿瘤发生中的作用。

Papillary Intralymphatic Angioendothelioma in a Child With -Related Overgrowth Spectrum: Implication of PI3K Pathway in the Vascular Tumorigenesis.

机构信息

Department of Pathology and Cell Biology, Columbia University-Irving Medical Center, New York, NY, USA.

出版信息

Pediatr Dev Pathol. 2023 Mar-Apr;26(2):166-171. doi: 10.1177/10935266231152370. Epub 2023 Feb 12.

DOI:10.1177/10935266231152370
PMID:36775953
Abstract

Papillary intralymphatic angioendothelioma (PILA) is an extremely rare vascular tumor and its pathogenesis is unknown. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum (PROS) is a heterogeneous group of disorders caused by mosaicism for activating mutations of and characterized by asymmetric overgrowth, skeletal anomalies, skin lesions, and vascular malformations. An association between PILA and PROS has not been known. We report a case of PILA involving the spleen of a young girl with the clinical and molecular diagnosis of PROS. Sequencing of the patient's germ-line DNA detected a pathogenic variant c.1357G>A in 10.6% of alleles. Splenectomy revealed a 4-cm tumor composed of ectatic lymphatics with intraluminal papillary projections, consistent with PILA. The tumor cells showed immunohistochemical expression of CD31, CD34, ERG, FLI-1, PROX1, and caldesmon, while D2-40 was negative. The latter may suggest that the tumor derived from an endothelial precursor arrested in the final steps of lymphothelial differentiation, in keeping with the known role of the -governed molecular pathway in the progression of vascular progenitors to mature endothelial cells. The data implicates in the pathogenesis of PILA and broadens the spectrum of phenotypic expressions of PROS.

摘要

乳头状淋巴管内血管内皮细胞瘤 (PILA) 是一种极其罕见的血管肿瘤,其发病机制尚不清楚。磷脂酰肌醇-4,5-二磷酸 3-激酶催化亚单位 α (PIK3CA) 相关过度生长谱 (PROS) 是一组由 和 激活突变镶嵌引起的异质性疾病,其特征为不对称性过度生长、骨骼异常、皮肤损伤和血管畸形。目前尚不知道 PILA 与 PROS 之间存在关联。我们报告了一例涉及年轻女孩脾脏的 PILA 病例,该患者具有 PROS 的临床和分子诊断。对患者的种系 DNA 进行测序,在 10.6%的等位基因中检测到致病性 变体 c.1357G>A。脾切除术显示一个 4 厘米大的肿瘤,由扩张的淋巴管组成,管腔内有乳头状突起,符合 PILA 的表现。肿瘤细胞表现出 CD31、CD34、ERG、FLI-1、PROX1 和钙调蛋白的免疫组化表达,而 D2-40 为阴性。后者可能表明肿瘤来源于一个内皮前体细胞,其在淋巴内皮分化的最后步骤中停滞不前,这与 调控的分子途径在血管祖细胞向成熟内皮细胞的进展中的作用是一致的。这些数据提示 在 PILA 的发病机制中起作用,并拓宽了 PROS 的表型表达谱。

相似文献

1
Papillary Intralymphatic Angioendothelioma in a Child With -Related Overgrowth Spectrum: Implication of PI3K Pathway in the Vascular Tumorigenesis.儿童伴 - 相关过度生长谱的乳腺内淋巴管内血管内皮瘤:PI3K 通路在血管肿瘤发生中的作用。
Pediatr Dev Pathol. 2023 Mar-Apr;26(2):166-171. doi: 10.1177/10935266231152370. Epub 2023 Feb 12.
2
Updates on Diagnosis and Treatment of PIK3CA-Related Overgrowth Spectrum.PIK3CA相关过度生长谱系疾病的诊断与治疗进展
Ann Plast Surg. 2023 May 1;90(5S Suppl 2):S209-S215. doi: 10.1097/SAP.0000000000003389. Epub 2022 Dec 21.
3
PIK3CA-related overgrowth spectrum (PROS): new insight in known diseases.PIK3CA 相关过度生长谱(PROS):已知疾病的新见解。
Med Clin (Barc). 2021 Nov 26;157(10):483-488. doi: 10.1016/j.medcli.2021.03.036. Epub 2021 Jul 16.
4
In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).在体外,变构 AKT 抑制剂 ARQ 092 对源自 PIK3CA 相关过度生长谱(PROS)患者的原代成纤维细胞的疗效。
Neurogenetics. 2018 May;19(2):77-91. doi: 10.1007/s10048-018-0540-1. Epub 2018 Mar 16.
5
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α(PIK3CA)相关过度生长谱系:简要报告。
Pediatr Dermatol. 2018 May;35(3):e186-e188. doi: 10.1111/pde.13441. Epub 2018 Mar 1.
6
Phenotypic and molecular characterization of five patients with PIK3CA-related overgrowth spectrum (PROS).五例PIK3CA相关过度生长谱系(PROS)患者的表型和分子特征
Am J Med Genet A. 2022 Jun;188(6):1792-1800. doi: 10.1002/ajmg.a.62709. Epub 2022 Mar 2.
7
[PIK3CA-related overgrowth syndrome (PROS)].[磷脂酰肌醇-3激酶催化亚基α相关过度生长综合征(PROS)]
Nephrol Ther. 2017 Apr;13 Suppl 1:S155-S156. doi: 10.1016/j.nephro.2017.02.004.
8
Complex vascular anomalies and tissue overgrowth of limbs associated with increased skin temperature and peripheral venous dilatation: parks weber syndrome or PROS?四肢复杂血管异常和组织过度生长,伴有皮肤温度升高和周围静脉扩张:Parks Weber 综合征还是 PROS?
Hereditas. 2022 Jan 4;159(1):1. doi: 10.1186/s41065-021-00217-6.
9
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.PIK3CA相关过度生长谱系(PROS):诊断及检测适用标准、鉴别诊断与评估
Am J Med Genet A. 2015 Feb;167A(2):287-95. doi: 10.1002/ajmg.a.36836. Epub 2014 Dec 31.
10
Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants.PIK3CA 相关过度生长谱和重叠病症中的基因型和表型异质性:150 例新患者和 1007 例 PIK3CA 致病性变异患者的系统回顾
J Med Genet. 2023 Feb;60(2):163-173. doi: 10.1136/jmedgenet-2021-108093. Epub 2022 Mar 7.

引用本文的文献

1
Transumbilical single-site laparoscopic resection of splenic papillary angioendothelioma in a pediatric patient: a rare case report and review of literature.小儿经脐单孔腹腔镜脾血管内皮细胞瘤切除术:1例罕见病例报告及文献复习
Front Oncol. 2025 Jul 14;15:1571209. doi: 10.3389/fonc.2025.1571209. eCollection 2025.
2
Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.贝克威思-维德曼综合征及其他易感综合征中肾母细胞瘤和肝母细胞瘤的监测进展
Clin Cancer Res. 2024 Dec 2;30(23):5260-5269. doi: 10.1158/1078-0432.CCR-24-2100.
3
Work-Up and Treatment Strategies for Individuals with -Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association.
与肢端肥大症相关障碍患者的评估和治疗策略:来自意大利肢端肥大症和 PROS 协会科学委员会专家的共识。
Genes (Basel). 2023 Nov 27;14(12):2134. doi: 10.3390/genes14122134.